1. Home
  2. CTSO vs PNBK Comparison

CTSO vs PNBK Comparison

Compare CTSO & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • PNBK
  • Stock Information
  • Founded
  • CTSO 1997
  • PNBK 1999
  • Country
  • CTSO United States
  • PNBK United States
  • Employees
  • CTSO N/A
  • PNBK N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • PNBK Major Banks
  • Sector
  • CTSO Health Care
  • PNBK Finance
  • Exchange
  • CTSO Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • CTSO 72.8M
  • PNBK 84.4M
  • IPO Year
  • CTSO N/A
  • PNBK N/A
  • Fundamental
  • Price
  • CTSO $0.89
  • PNBK $1.58
  • Analyst Decision
  • CTSO Buy
  • PNBK
  • Analyst Count
  • CTSO 2
  • PNBK 0
  • Target Price
  • CTSO $5.50
  • PNBK N/A
  • AVG Volume (30 Days)
  • CTSO 351.0K
  • PNBK 348.5K
  • Earning Date
  • CTSO 08-07-2025
  • PNBK 08-26-2025
  • Dividend Yield
  • CTSO N/A
  • PNBK N/A
  • EPS Growth
  • CTSO N/A
  • PNBK N/A
  • EPS
  • CTSO N/A
  • PNBK N/A
  • Revenue
  • CTSO $36,107,520.00
  • PNBK $15,640,000.00
  • Revenue This Year
  • CTSO $11.15
  • PNBK N/A
  • Revenue Next Year
  • CTSO $21.39
  • PNBK N/A
  • P/E Ratio
  • CTSO N/A
  • PNBK N/A
  • Revenue Growth
  • CTSO 20.18
  • PNBK N/A
  • 52 Week Low
  • CTSO $0.71
  • PNBK $0.90
  • 52 Week High
  • CTSO $1.61
  • PNBK $7.47
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 41.50
  • PNBK 47.65
  • Support Level
  • CTSO $1.03
  • PNBK $1.51
  • Resistance Level
  • CTSO $1.19
  • PNBK $1.67
  • Average True Range (ATR)
  • CTSO 0.09
  • PNBK 0.15
  • MACD
  • CTSO 0.01
  • PNBK -0.01
  • Stochastic Oscillator
  • CTSO 27.21
  • PNBK 19.05

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: